Antibacterial Haemostatic Gels Market Share

  • Report ID: 5907
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Antibacterial Haemostatic Gels Market Share

North American Market Analysis

North America industry is predicted to dominate majority revenue share of 43% by 2037. This growth will be noticed owing to the rising advancement of healthcare infrastructure in this region. In many ways, the US economy is made up of the healthcare sector. It plays a significant role in people's lives by maintaining their well-being and health. Additionally, its budgetary implications and economic size matter. According to the authors 'calculations and the Bureau of Labor Statistics, the healthcare sector now accounts for 24 percent of government spending and employs 11 percent of American workers.

APAC Market Statistics

The antibacterial haemostatic gels market in the Asia Pacific region will also encounter huge growth during the forecast period and will hold the second position owing to the increasing prevalence of chronic disease in this region. The most populated nation, China, is aging at an unprecedented rate. In 2020, about one in five Chinese people was over 60 years of age. By 2050, this figure, which accounts for 25% of the world's older population, is projected to rise to 1 in 3. Globally, older adults are more susceptible to chronic diseases than younger adults, and older adults are the main cause of premature adult deaths.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5907
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of antibacterial haemostatic gels is evaluated at USD 1.57 billion.

The antibacterial haemostatic gels market size was valued at USD 1.49 billion in 2024 and is set to exceed USD 3.3 billion by 2037, expanding at over 6.3% CAGR during the forecast period i.e., between 2025-2037. The increase in surgical techniques across the world will drive the market growth.

North America industry is predicted to dominate majority revenue share of 43% by 2037, owing to rising advancement of healthcare infrastructure in this region.

The major players in the market are Pfizer Inc., DEXX Laboratories Inc., Medura, StopBleed, Zoetis Inc., Rapid-Seal, Coloplast Group, Gel-e-life sciences, PREVESTDenPro, Bio-Chem LLC, Smith & Nephew, Medtronic, B. Braun SE, 3M.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample